ASPIRA WOMEN'S HEALTH INC (AWH)
US04537Y2081 - Common Stock
Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
Coverage represents approximately 6 million lives, including commercial, Medicare Advantage, and Medicaid...
AWH Stock Earnings: Aspira Womens Health Beats EPS, Misses Revenue for Q4 2023
AWH stock results show that Aspira Womens Health beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
2023 OvaSuite revenue of $9.2 million, an increase of 15% year-over-year 2023 OvaSuite volume of 23,990 units, an increase of 12% year-over-year Cash...
Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference
AUSTIN, Texas, March 21, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s...
Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024
AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s...
Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference
AUSTIN, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s...
Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)
AUSTIN, Texas, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company...
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024
AUSTIN, Texas, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s...
Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024
Aspira management will be available for meetings in San Francisco (January 8-10, 2024) AUSTIN, Texas, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s...
Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis
Data supports EndoCheck™ to be the first blood test for the identification of localized endometriosis, including endometrioma Platform migration to begin...
Aspira Women’s Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)
California Medicaid (Medi-Cal) added Ova1Plus(R) to its fee schedule at $897 per test...
Aspira Women’s Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)
CMS approves OvaWatchSM 2024 price at $897 per test AUSTIN, Texas, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the...
Aspira Women’s Health Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatch
The proposed rule would allow for OvaWatchSM to be reimbursed at the same rate as Ova1® at $897 per test and will become final following a brief public...
Aspira Women’s Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research
Data showed miRNA-protein models potential to improve the diagnostic accuracy of non-invasive ovarian cancer tests...
Aspira Women’s Health to Present at the BioVenture Nexus Conference
The conference is taking place on October 5-6, 2023, in Los Angeles, CA...
Aspira Women's Health CFO buys 2,246 shares in the company (NASDAQ:AWH)
Aspira Women's Health (AWH) disclosed on Sept. 12 that its CFO Hombeck Torsten bought 2,246 shares in the company at a price of $4.3 on Sept
Eleventh-Hour Climbers: 7 Stocks Gearing Up for a Late Summer Surge
If you have the patience and risk tolerance for highly speculative ideas, these are trades benefitting from a late summer stock surge.
Aspira Women’s Health Signs Exclusive Sample Procurement Agreement with The University of Oxford
Samples to be used in validating the Company’s EndoCheckSM test in development for the diagnosis of endometriosis AUSTIN, Texas, Aug. 31, 2023 (GLOBE...
Aspira Women’s Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations
AUSTIN, Texas, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc.(“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused...
Aspira Women’s Health® Reports Second Quarter 2023 Financial Results
Continued growth trend with second quarter revenue of $2.5 million, an increase of 23% over the second quarter of 2022. OvaSuiteSM volume of 6,289...
Aspira Women’s Health COO to step down (NASDAQ:AWH)
Aspira Women’s Health Inc (AWH) on Wednesday announced that Ryan Phan is stepping down as the company’s Chief Scientific and Operating Officer effective September 15.Phan is expected...
Aspira Women’s Health Announces Transition of its Chief Scientific Officer/Chief Operating Officer
AUSTIN, Texas, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s...
Aspira Women’s Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023
AUSTIN, Texas, July 31, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on the...